Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
18,416 total articles
Eagle Nuclear Energy Corp. has initiated comprehensive environmental baseline studies prior to a 27,000 ft Pre-Feasibility Study drilling program at its Aurora Uranium Project located on the Oregon-Nevada border. These studies cover hydrology, geochemistry, flora and fauna, wetlands, meteorology, and cultural heritage to facilitate environmental im…
Achieve Life Sciences, a specialty pharmaceutical company focused on cytisinicline for nicotine dependence treatment, announced it will release its Q1 2026 financial results and hold a conference call on May 12, 2026. The announcement comes as the FDA is reviewing its New Drug Application with a PDUFA date set for June 20, 2026, potentially approvi…
InterDigital, Inc., a leading wireless, video, and AI technology research and development company, announced it will present at four major investor conferences between May and June 2026. These presentations will showcase the company's latest technological advancements and strategic outlook in wireless communications, video processing, and AI sector…
HomeTrust Bancshares, Inc., the holding company of HomeTrust Bank, has been named to the 2026 KBW Bank Honor Roll for the second consecutive year, recognizing best-in-class earnings growth over the past decade. Additionally, the company earned a spot on Forbes' 2026 list of America’s Best Banks for the third consecutive year and was recognized as a…
SS Innovations International, Inc. announced that its SSi Mantra surgical robotic system has surpassed 10,500 cumulative surgeries across multiple specialties since its commercial launch in August 2022. The system has been used in multi-specialty procedures including cardiac, pediatric, and telesurgeries, with over 2,100 physicians trained and more…
Weatherford has been awarded multiple managed pressure drilling contracts and a global aftermarket agreement with Noble Corporation, enhancing their partnership and reinforcing Weatherford's leadership in MPD systems. The contracts include deepwater MPD systems for Noble's Guyana operations and upgrades for Nigerian deployments, along with global a…
Oragenics, Inc. has launched a second clinical trial site in Australia for its Phase IIa study of ONP-002, a novel intranasal neurosteroid designed to treat concussion and mild traumatic brain injury (mTBI). The ongoing trial aims to enroll 40 patients and has already dosed four patients at the first site, reflecting strong demand due to the lack o…
Virtuix Inc. (NASDAQ: VTIX) has been chosen by the U.S. Marine Corps Training and Education Command to lead the development and integration of a multi-user virtual reality infantry training system utilizing four Omni One omni-directional treadmills. This system allows a four-person Marine fire team to physically move together in a shared virtual en…
Ocugen, Inc. announced the pricing of $115 million of 6.75% Convertible Senior Notes due 2034 in a private offering to qualified institutional buyers. Net proceeds will be used to fully repay existing loans and fund general corporate purposes. The notes carry an initial conversion price premium of approximately 45%, with conversion beginning no soo…
Portillo's Inc. released its first quarter 2026 financial results showing a 3.5% revenue increase to $182.6 million driven by new restaurant openings. However, same-restaurant sales declined slightly, and the company reported a net loss of $0.5 million compared to net income in the prior year. Operating income and Adjusted EBITDA both fell due to h…
Madrigal Pharmaceuticals announced an exclusive global license agreement to acquire ARO-PNPLA3, a clinical-stage siRNA asset targeting the PNPLA3 gene, a key genetic driver of Metabolic dysfunction-associated steatohepatitis (MASH). The addition enhances Madrigal's precision medicine strategy in MASH treatment, particularly benefiting Hispanic popu…
Apollo Global Management announced the final close of Apollo Hybrid Value Fund III, raising approximately $6.5 billion. The fund attracted a wide range of global institutional investors and focuses on hybrid capital strategies that blend debt and equity features to provide flexible, partnership-oriented investment solutions. This fund follows two p…
Picard Medical, Inc., listed on NYSE American as PMI, announced the pricing of a $5 million offering consisting of common stock, pre-funded warrants, and common warrants to institutional investors. The proceeds will be used for working capital, general corporate purposes, and to pay down senior secured notes and working capital loans. The offering …
Powell Industries, a leading provider of custom engineered electrical energy management solutions, declared a quarterly cash dividend of $0.09 per share payable June 17, 2026, to shareholders of record May 20, 2026. The company serves major industries including oil and gas, electric utilities, and industrial markets.
Enphase Energy, Inc., a leader in microinverter-based solar and energy storage systems, will hold its 2026 Annual Meeting of Stockholders on May 13, 2026, at its headquarters in Fremont, California. The meeting includes a CEO presentation by Badri Kothandaraman, accessible online and by phone. Additional details are provided in the company's proxy …
Septerna, Inc., a clinical-stage biotech company specializing in GPCR drug discovery, announced that its CEO Jeffrey Finer will present at the Bank of America Securities Health Care Conference on May 12, 2026. The presentation will be webcast live and archived on the company's website. Septerna focuses on developing novel oral small molecule therap…
Zentalis Pharmaceuticals announced dosing of the first patient in its global Phase 3 ASPENOVA trial evaluating azenosertib, a first-in-class WEE1 inhibitor, against standard chemotherapy in Cyclin E1-positive platinum-resistant ovarian cancer patients. The trial supports a confirmatory study to complement the ongoing Phase 2 DENALI trial aiming for…
IZEA Worldwide, a leading influencer marketing company, announced its financial results conference call for first quarter 2026 will be held on May 12, 2026. The call will be hosted by the CEO and CFO and include a Q&A session. Investors are invited to attend via webcast or phone, with a replay available for a week. The company highlights its positi…
Neuronetics, Inc. announced its Q1 2026 financial results showing an 8% increase in total revenues to $34.5 million driven by a 15% growth in U.S. clinic revenue. The company reduced operational cash burn and operating expenses, while expanding access to NeuroStar Advanced Therapy through new payer policies. Despite a net loss, improved cash flow a…
Core AI Holdings has appointed Sonali Garg, co-founder and COO of Allianca Group and former Meta data center leader, to its advisory board. This move enhances Core AI's execution capabilities as it advances its AI-ready data center platform in strategic partnership with Allianca, which specializes in rapid and scalable data center delivery. Garg br…
Enovix Corporation announced the appointment of Steve Bakos as Senior Vice President of Worldwide Sales to support the commercialization and scaling of its advanced silicon-anode lithium-ion batteries. This leadership addition comes at a pivotal time as Enovix aligns with a lead smartphone customer on a silicon-specific qualification framework, aim…
Nexentis Technologies Inc., through its wholly owned subsidiary MitoCareX Bio Ltd., announced the official U.S. trademark registration of its proprietary algorithm platform MITOLINE™, designed to advance mitochondrial drug discovery by enabling robust 3D modeling of mitochondrial carrier proteins. This milestone strengthens the company’s drug disco…
Nuvectis Pharma reported its financial results for Q1 2026 and provided updates on its clinical-stage oncology drug NXP900. The Phase 1b trial continues enrolling patients in the US, with preclinical data showing promising synergy of NXP900 combined with RAS inhibitor sotorasib in lung cancer models. The company maintains financial discipline, with…
GD Culture Group Limited announced the receipt of a non-binding proposal from a consortium to acquire all outstanding shares not already owned by the consortium for $10.75 per share in cash, representing a premium of approximately 169% over recent trading prices. The Board plans to evaluate the offer and consider forming a special committee to nego…
Willis Towers Watson (WTW) has completed its acquisition of UK workplace pension and savings provider Cushon, following regulatory approval. This acquisition solidifies WTW's position as the fourth largest master trust provider in the UK defined contribution workplace pensions market, managing over £30 billion in assets for 1.2 million members. The…
